Sixfold Bioscience
About:
Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.
Website: https://www.sixfold.bio/
Twitter/X: sixfold_bio
Top Investors: Y Combinator, Bossanova Investimentos, Innovate UK, European Commission, Cantos
Description:
Sixfold Bioscience engineers programmable oligonucleotide delivery systems are able to deliver RNA exclusively to diseased cells. It is based in London.
Total Funding Amount:
$10.6M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
London, England, United Kingdom
Founded Date:
2018-01-01
Contact Email:
info(AT)sixfold.bio
Founders:
Anna Perdrix Rosell, George Foot, Zuzanna Brzosko
Number of Employees:
11-50
Last Funding Date:
2021-12-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai